D.E. Shaw & Co
CLVS

D.E. Shaw & Co’s Clovis Oncology, Inc. CLVS Stock Holding History

D.E. Shaw & Co’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100,000
Closed -$1.04M – 4375
2019
Q4 		$1.04M Buy
100,000
+30,000
+43% +$218K ﹤0.01% 2954
2019
Q3 		$275K Hold
70,000
– – ﹤0.01% 3506
2019
Q2 		$1.04M Hold
70,000
– – ﹤0.01% 2653
2019
Q1 		$1.74M Sell
70,000
-152,400
-69% -$3.82M ﹤0.01% 2249
2018
Q4 		$3.99M Hold
222,400
– – 0.01% 1653
2018
Q3 		$6.53M Buy
222,400
+25,000
+13% +$968K 0.01% 1395
2018
Q2 		$8.98M Buy
197,400
+9,800
+5% +$477K 0.01% 1149
2018
Q1 		$9.9M Buy
187,600
+10,000
+6% +$583K 0.01% 1005
2017
Q4 		$12.1M Buy
177,600
+20,000
+13% +$1.4M 0.02% 920
2017
Q3 		$13M Buy
157,600
+57,600
+58% +$4.57M 0.02% 793
2017
Q2 		$9.36M Buy
100,000
+20,000
+25% +$1.22M 0.02% 943
2017
Q1 		$5.09M Buy
80,000
+31,000
+63% +$1.88M 0.01% 1282
2016
Q4 		$2.18M Buy
49,000
+40,000
+444% +$1.41M ﹤0.01% 1930
2016
Q3 		$324K Buy
+9,000
New +$193K ﹤0.01% 3016
2016
Q1 		– Sell
-9,000
Closed -$315K – 3870
2015
Q4 		$315K Hold
9,000
– – ﹤0.01% 3342
2015
Q3 		$828K Buy
+9,000
New +$779K ﹤0.01% 2728
2015
Q2 		– Sell
-7,500
Closed -$557K – 3921
2015
Q1 		$557K Buy
+7,500
New +$530K ﹤0.01% 2991
2014
Q4 		– Sell
-30,000
Closed -$1.36M – 4331
2014
Q3 		$1.36M Buy
+30,000
New +$1.25M ﹤0.01% 2553

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

D.E. Shaw & Co's CLVS Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 44,924 shares — an estimated $53K sold.

D.E. Shaw & Co first reported a position in CLVS in Q2 2013 and held it in 35 quarters. The position peaked at $104M in Q1 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 44,924 Clovis Oncology, Inc. shares in Q4 2022, an estimated $53K.
  • D.E. Shaw & Co first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 35 quarters.
  • D.E. Shaw & Co's Clovis Oncology, Inc. position peaked at $104M in Q1 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.